Renatone 0.13 g Solution is a Health Canada–registered veterinary drug (DIN 00445088) held by Vetoquinol N A Inc, containing Methenamine. Health Canada lists its status as Cancelled Post Market (status date 17 Jul 2009). Nexara Health has matched 60 registrations of Methenamine across 9 other regulated markets.
Health Canada registration
| DIN | 00445088 |
|---|---|
| Brand name | Renatone |
| Active ingredient | Methenamine |
| Strength | 0.13 g |
| Dosage form | Solution |
| Route | Oral |
| Company | Vetoquinol N A Inc |
| Status | Cancelled Post Market — 17 Jul 2009 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Methenamine registered in other markets
60 registrations of the same molecule in 9 national registries outside Canada (first 30 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | APOHEALTH Urinary Tract Antibacterial | Tx | Tablet containing methenamine hippurate 1 g | GE | PBS | |
| Australia | Hiprex | Il | Tablet containing methenamine hippurate 1 g | GE | PBS | |
| Denmark | Haiprex | Viatris ApS | 1 g | tabletter | National | Laegemiddelstyrelsen |
| Denmark | Hiprex | Orifarm A/S | 1 g | tabletter | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Methenamine hippurate "EQL Pharma" | EQL Pharma AB | 1 g | tabletter | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Methenamine hippurate "Zentiva" | Zentiva k.s. | 1 g | tabletter | Decentral procedure | Laegemiddelstyrelsen |
| Ireland | Methenamine hippurate Brown & Burk 1 g tablets | Brown & Burk IR Limited | Tablet | Not marketed | HPRA | |
| Malta | Hiprex 1g tablets | Focused Pharma Ltd | Tablet | Authorised | Medicines Authority | |
| Malta | Methenamine Hippurate Brown & Burk 1g Tablets | Brown & Burk IR Limited | Tablet | Authorised | Medicines Authority | |
| Malta | Methenamine hippurate EQL Pharma 1 g tablets | EJ Busuttil Ltd | Tablet | Authorised | Medicines Authority | |
| Netherlands | Xcyst 500 mg, maagsapresistente tabletten | ACE Pharmaceuticals B.V. | Maagsapresistente tablet | Uitsluitend recept | EU national register | |
| Taiwan | Mandelamine S.c. Tablets 0.25gm (Methenamine ) | 派德股份有限公司 | 糖衣錠 | 已註銷 | TFDA | |
| Taiwan | Mandelamine Suspension | Warner Chilcott Lab. Division Of Warner-Lambert Pham. Co. | 懸液劑 | 已註銷 | TFDA | |
| Taiwan | Mandelamine Tablets 0.5g | Warner Chilcott Lab. Division Of Warner-Lambert Pham. Co. | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Mandelamine Tablets 1gm | Warner Chilcott Lab. Division Of Warner-Lambert Pham. Co. | 錠劑 | 已註銷 | TFDA | |
| Taiwan | Methenamine Mandelate "Delmar" | Delmar Chemicals Co., Ltd | （粉） | 已註銷 | TFDA | |
| Taiwan | Methenamine Mandelate "Sumitomo" | Sumitomo Pharmaceuticals Co., Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Methenamine Mandelate (Mandelamine) | Warner Lambert Co. | （粉） | 已註銷 | TFDA | |
| Turkey | Hippurin 1 Gr 28 Film Tablet | Recordati̇ İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Purinol Efervesan 140 Gr Granul | Recordati̇ İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| Turkey | Purinol Efervesan 70 Gr Granul | Recordati̇ İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Aktif | TITCK | ||
| United Kingdom | Methenamine hippurate 1g tablets | — | 0001 | NHS dm+d VMP | ||
| United States | Methenamine | Spectrum Laboratory Products, Inc. | Crystal | FDA NDC | ||
| United States | Methenamine | Chattem Chemicals, Inc. | Powder | FDA NDC | ||
| United States | Methenamine | Guangzhou Hanpu Pharmaceutical Co Ltd | Powder | FDA NDC | ||
| United States | Methenamine hippurate | Zydus Lifesciences Limited | Tablet | listed | FDA NDC | |
| United States | Methenamine hippurate | Viona Pharmaceuticals Inc | Tablet | listed | FDA NDC | |
| United States | Methenamine Hippurate | American Health Packaging | Tablet | listed | FDA NDC | |
| United States | Methenamine Hippurate | Siegfried Evionnaz SA | Powder | FDA NDC | ||
| United States | Methenamine Hippurate | Micro Labs Limited | Tablet | listed | FDA NDC |
See every manufacturer of Methenamine worldwide →
Regulator price references for Methenamine
Published list or reimbursement prices for Methenamine presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Uramet | Tablet containing methenamine hippurate 1 g | 17.02 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Uramet | Tablet containing methenamine hippurate 1 g | 17.02 AUD | ex-manufacturer | PBS | 2026-09-08 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Renatone (DIN 00445088) marketed in Canada?
No. Health Canada lists DIN 00445088 as Cancelled Post Market as of 17 Jul 2009.
Who holds the Canadian licence for this product?
Vetoquinol N A Inc is the company of record in the Health Canada Drug Product Database.
Is Methenamine registered outside Canada?
Yes — Nexara Health has matched 60 registrations in 9 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00445088, status date 2009-07-17; national medicine registries: EU national register, FDA NDC, HPRA, Laegemiddelstyrelsen, Medicines Authority, NHS dm+d VMP, PBS, TFDA, TITCK; price sources: PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00445088, status date 2009-07-17; national medicine registries: EU national register, FDA NDC, HPRA, Laegemiddelstyrelsen, Medicines Authority, NHS dm+d VMP, PBS, TFDA, TITCK; price sources: PBS.
Health Canada Drug Product Database (DPD), DIN 00445088, status date 2009-07-17; national medicine registries: EU national register, FDA NDC, HPRA, Laegemiddelstyrelsen, Medicines Authority, NHS dm+d VMP, PBS, TFDA, TITCK; price sources: PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.